E2F1 Reduces Sorafenib’s Sensitivity of Esophageal Carcinoma Cells via Modulating the miR-29c-3p/COL11A1 Signaling Axis
Journal:
Current Molecular Pharmacology
Volume:
17
Page:
1-25
Author(s):
Zhifeng Ma, Ting Zhu, Haiyong Wang, Bin Wang, Linhai Fu and Guangmao Yu*
Targeting Mutant-p53 for Cancer Treatment: Are We There Yet?
Journal:
Current Molecular Pharmacology
Volume:
17
Page:
1-16
Author(s):
Dhi Vya Lim, Wei Hwei Woo, Jing Xuan Lim, Xin Yee Loh, Hui Ting Soh, Seng Yung Adrian Lim, Zheng Yang Lee, Hui Yin Yow, Sharina Binti Hamzah, Renukha Sellappans and Jhi Biau Foo*
Regulating miRNAs Expression by Resveratrol: Novel Insights based on Molecular Mechanism and Strategies for Cancer Therapy
Journal:
Current Molecular Pharmacology
Volume:
17
Page:
1-21
Author(s):
Atoosa Keshavarzmotamed, Vahide Mousavi, Niloufar Masihipour, Atefe Rahmati, Rohollah Mousavi Dehmordi, Behrooz Ghezelbash, Mina Alimohammadi* and Alireza Mafi*
IMPDH2 Positively Impacts the Proliferation Potential of Hepatoblastoma Cells by Activating JunB Signaling Pathway
Journal:
Current Molecular Pharmacology
Volume:
17
Page:
1-16
Author(s):
Li Yuan*, Liang Zeng, Feng Ye, Kai Chen, Zhengrong Chen and Liping Li
Anticancer Properties of Baicalin against Breast Cancer and other Gynecological Cancers: Therapeutic Opportunities based on Underlying Mechanisms
Journal:
Current Molecular Pharmacology
Volume:
17
Page:
1-10
Author(s):
Mohammad Hossein Pourhanifeh, Hossein Farrokhi-Kebria, Parsa Mostanadi, Tahereh Farkhondeh and Saeed Samarghandian*
Hsa_Circ_0000021 Sponges miR-3940-3p/KPNA2 Expression to Promote Cervical Cancer Progression
Journal:
Current Molecular Pharmacology
Volume:
17
Page:
1-13
Author(s):
Qingyuan Zeng, Kun Feng, Yang Yu and Yumei Lv*
Deregulated MicroRNAs involved in P53 Signaling Pathway in Breast Cancer with Focus on Triple-negative Breast Cancer
Journal:
Current Molecular Pharmacology
Volume:
17
Page:
1-20
Author(s):
Yasaman Naeimzadeh, Zahra Heidari, Vahid Razban* and Sahar Khajeh*
PF-04449913 Inhibits Proliferation and Metastasis of Colorectal Cancer Cells by Down-regulating MMP9 Expression through the ERK/p65 Pathway
Journal:
Current Molecular Pharmacology
Volume:
17
Page:
1-13
Author(s):
Yejiao Ruan, Guangrong Lu, Yaojun Yu, Yue Luo, Hao Wu, Yating Shen, Zejun Gao, Yao Shen, Zhenzhai Cai* and Liyi Li*
Artemisinin Attenuates Isoproterenol-induced Cardiac Hypertrophy via the ERK1/2 and p38 MAPK Signaling Pathways
Journal:
Current Molecular Pharmacology
Volume:
17
Page:
1-11
Author(s):
Renxing Song, Chunming Xiong, Juncai Bai, Zhenzhou Bai and Wei Liu*
At the Crossroads of TNF α Signaling and Cancer
Journal:
Current Molecular Pharmacology
Volume:
17
Page:
1-20
Author(s):
Sonal M. Manohar*